This trial is to develop improved methods for fetal cell recovery and analysis from the mother's blood, in order to create clinically useful noninvasive prenatal tests (NIPT). Luna Genetics will collect and analyze blood samples from pregnant women, healthy adult males, and non-pregnant females. Control samples will be collected from healthy adult males and non-pregnant females.
1 Primary · 0 Secondary · Reporting Duration: 3 years
Awards & Highlights
0 Treatment Group
500 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 65 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
Is enrollment for this experiment open at the present?
"Yes, clinicaltrials.gov confirms that this medical study is currently recruiting participants and opened for enrollment on the 12th of January 2022. The trial was last modified on 16th February 2022, with 500 patients being recruited from a single site." - Anonymous Online Contributor
Can participants aged 35 and younger apply for this medical study?
"To be eligible, patients must between 18 and 65 years of age. For those under the legal consenting age (18) there are 24 trials open for enrollment; for senior citizens (over 65), 87 studies currently have patient recruitment underway." - Anonymous Online Contributor
What is the current enrollment count for this experiment?
"Yes, the research is currently being conducted according to the information posted on clinicaltrials.gov; it was first advertised in December of 2022 and has recently been updated as of February 16th 2022. This trial needs 500 people from a single location." - Anonymous Online Contributor
Am I able to participate in this investigation?
"To qualify, potential participants must be of childbearing age and between 18-65 years old. This clinical trial is seeking to enrol 500 people in total." - Anonymous Online Contributor